Omnispirant Limited Patents

Patent portfolio assigned to Omnispirant Limited (verified via public assignee records). Estimated patent count: 1. Irish biotech (Galway), inhaled stem-cell exosome (OmniSome) gene therapy platform for cystic fibrosis/COPD/ARDS/lung cancer. Named partners are R&D consortium/collaboration partners (DTIF consortium with Aerogen + NUI Galway; EVerZom co-development), not paying customers. Patent US20210308067A1 'Extracellular vesicles for inhalation' confirmed assigned to OMNISPIRANT LIMITED on Google Patents; at least 1 patent (additional family members likely).